期刊文献+

Simultaneous LC-MS/MS Determination of Danshensu and Paeoniflorin for Permeability Studies in Caco-2 Intestinal Absorption Model 被引量:1

Simultaneous LC-MS/MS Determination of Danshensu and Paeoniflorin for Permeability Studies in Caco-2 Intestinal Absorption Model
下载PDF
导出
摘要 A high sensitive method based on liquid chromatography tandem mass spectrometry(LC-MS/MS) was developed and validated for the study of permeability of danshensu(DS) and paeoniflorin(PF) in Caco-2 intestinal absorption model. The DS and PF were extracted from cell culture by vacuum-lyophilizing and then separated on a Zorbax Stable Bond C18 column with 0.1% acetic acid aqueous solution and methanol as mobile phase. Detection was carried out by negative electrospray ionization(ESI ) with selected reaction monitoring(SRM) mode. The apparent permeability coefficients(Papp) of DS and PF in Caco-2 cell medium were calculated and the effects of verapamil on the coefficients Papp of the two test compounds were also illustrated. The permeability of PF was much better than that of DS when the two compounds were administrated individually. Co-administration of DS and PF led to the decrease of the transport from apical side to basolateral side for both the compounds. However, the transport in the contrary direction were accelerated. It was also observed that verapamil could accelerate the transport of the test compounds from apical side to basolateral side. However, the absorption-enhanced effect of verapamil was attenuated when DS and PF were co-administrated. These observations suggest that both passive diffusion and active efflux involved in P-gp would effect the passage of DS and PF across Caco-2 cell monolayer. At the same time, the co-administration of DS and PF to an alteration of transport behavior, which suggests that the interaction must be taken into account when ‘n-in-one' samples were used in Caco-2 intestinal model. A high sensitive method based on liquid chromatography tandem mass spectrometry(LC-MS/MS) was developed and validated for the study of permeability of danshensu(DS) and paeoniflorin(PF) in Caco-2 intestinal absorption model. The DS and PF were extracted from cell culture by vacuum-lyophilizing and then separated on a Zorbax Stable Bond C18 column with 0.1% acetic acid aqueous solution and methanol as mobile phase. Detection was carried out by negative electrospray ionization(ESI ) with selected reaction monitoring(SRM) mode. The apparent permeability coefficients(Papp) of DS and PF in Caco-2 cell medium were calculated and the effects of verapamil on the coefficients Papp of the two test compounds were also illustrated. The permeability of PF was much better than that of DS when the two compounds were administrated individually. Co-administration of DS and PF led to the decrease of the transport from apical side to basolateral side for both the compounds. However, the transport in the contrary direction were accelerated. It was also observed that verapamil could accelerate the transport of the test compounds from apical side to basolateral side. However, the absorption-enhanced effect of verapamil was attenuated when DS and PF were co-administrated. These observations suggest that both passive diffusion and active efflux involved in P-gp would effect the passage of DS and PF across Caco-2 cell monolayer. At the same time, the co-administration of DS and PF to an alteration of transport behavior, which suggests that the interaction must be taken into account when ‘n-in-one' samples were used in Caco-2 intestinal model.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2008年第4期420-426,共7页 高等学校化学研究(英文版)
基金 the National Basic Research Priorities Program of China(No. 2005CB523402) the Natural Science Foundation of Zhejiang Province,China(No.Y204418) the Program for New Century Excellent Talents in University of China (No.NCET-06-0515)
关键词 Denshensu PAEONIFLORIN Caco-2 cell Apparent permeability coefficient LC-MS/MS Denshensu Paeoniflorin Caco-2 cell Apparent permeability coefficient LC-MS/MS
  • 相关文献

参考文献23

  • 1Artursson E, Karlsson J., Biochem. Biophys. Res. Commun., 1991, 3, 880
  • 2Larger E, Altamura M., Catalioto R. M., et al., Anal. Chem., 2002, 20, 5273
  • 3Hakala K. S., Laitinen L., Kaukonen A. M., et al., Anal. Chem., 2003, 21, 5969
  • 4Zhang L., Chow M. S. S., Zuo Z., J. Pharm. Pharmacol., 2006, 1, 37
  • 5Dong Q. Q., Li E, Wen X. D., Chinese Journal of Natural Medicines, 2007, 1, 59
  • 6Doppenschmitt S., Spahn-Langguth H., Regardh C. G., et al., J Pharm. Sci., 1999, 10, 1067
  • 7Liu Z. Q., Zhou H., Liu L., et al., J Ethnopharmacol., 2005, 1, 61
  • 8Yu K., Wang Y. W., Cheng Y. Y., Chromatographia, 2006, 7/8, 359
  • 9He Q., Hu X. J., Cheng Y. Y., J. Pharm. Biomed. Anal., 2006, 2, 485
  • 10Zhao F. Q., Zheng N. X., Sato H., et al., Biol. Pharmacol. Bull., 1997, 3, 285

同被引文献12

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部